According to the GuruFocus All-In-One Screener as of Monday, the following health care stocks are popular among gurus.
Tandem Diabetes Care Inc. (TNDM, Financial) is held by four gurus
The company, which provides products for people with insulin-dependent diabetes, has a market cap of $3.59 billion. Its revenue of $330.11 million has fallen 37.60% over a 10-year period.
The stock is trading with a price-book ratio of 20.7. The share price of $58 is 18.78% below the 52-week high and 106.46% above the 52-week low. Over the past 10 years, it has lost 68.45%.
The company’s largest guru shareholder is Jim Simons (Trades, Portfolio)’ Renaissance Technologies with 2.25% of outstanding shares, followed by Steven Cohen (Trades, Portfolio) with 0.37% and Chuck Royce (Trades, Portfolio) with 0.09%.
Taro Pharmaceutical Industries Ltd. (TARO, Financial) is held by four gurus
The pharmaceutical company, which develops semi-solid formulations, has a market cap of $3.58 billion. Its revenue of $678.45 million has grown 9.90% over the past 10 years.
The stock is trading with a price-book ratio of 1.77. The share price of $92.83 is 15.16% below the 52-week high and 27.22% above the 52-week low. Over the past decade, it has returned 925.75%.
Simons’ firm is the company's largest guru shareholder with 1.51% of outstanding shares, followed by Hotchkis & Wiley with 0.17%, Charles Brandes (Trades, Portfolio) with 0.14% and Caxton Associates (Trades, Portfolio) with 0.02%.
Iovance Biotherapeutics Inc. (IOVA, Financial) is held by three gurus
The pharmaceutical manufacturer, which provides products to treat serious diseases such as cancer, has a $3.30 billion market cap.
The stock is trading with a price-book ratio of 9.29. The price of $26.14 is 1.69% below the 52-week high and 260.06% above the 52-week low. Over the past 10 years, it has lost 79.07%.
The company’s largest guru shareholder is Cohen with 0.62% of outstanding shares, followed by Louis Moore Bacon (Trades, Portfolio) with 0.10% and Simons’ firm 0.05%.
GW Pharmaceuticals PLC (GWPH, Financial) is held by four gurus.
The company, which develops botanical extracts’ medicines derived from the Cannabis Sativa plant, has a market cap of $3.30 billion. Its revenue of $208 million has fallen 12.40% over the past decade.
The stock is trading with a price-book ratio of 4.64. The share price of $106.62 is 45.60% below the 52-week high and 18.28% above the 52-week low. Over the past 10 years, it has returned 1,087%.
With 2.95% of outstanding shares, Cohen is the company's largest guru shareholder, followed by Simons' firm with 0.97%, Bacon with 0.03% and Pioneer Investments (Trades, Portfolio) with 0.01%.
Alkermes PLC (ALKS, Financial) is held by seven gurus
The company, which provides pharmaceutical products designed for unmet medical needs in major therapeutic areas, has a $3.29 billion market cap. Its revenue of $1.07 billion has grown 11.90% over the past 10 years.
The share price of $20.87 is 44.72% below the 52-week high and 21.98% above the 52-week low. Over the past decade, it has returned 136.35%.
The company’s largest guru shareholder is PRIMECAP Management (Trades, Portfolio) with 13.91% of outstanding shares, followed by the Vanguard Health Care Fund (Trades, Portfolio) with 8.30%, Simons’ firm with 3.11%, Ken Fisher (Trades, Portfolio) with 0.07%, Pioneer Investments with 0.05%, Paul Tudor Jones (Trades, Portfolio) with 0.02% and Jeff Auxier (Trades, Portfolio) with 0.02%.
Disclosure: I do not own any stocks mentioned.
Read more here:
- 6 Dividend Stocks Trading at a Discount
- 6 Guru Stocks Expanding Earnings
- 6 Guru Stocks Beating the Market
 Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
